Stomach cancer study seeks clues in gene silencing

NCT ID NCT06982768

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a specific gene change (called hMLH1 hypermethylation) affects stomach cancer. Researchers will study 245 patients who had stomach cancer surgery to find links between lifestyle, genetics, and how the cancer behaves. The goal is to better understand why some stomach cancers resist standard chemotherapy and to develop a tool that predicts which treatments will work best for each patient.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UOC Chirurgia Generale 1 - Fondazione Policlinico Universitario A. Gemelli IRCCS

    RECRUITING

    Rome, 00168, Italy

    Contact Phone: •••-•••-••••